Options for screening for gestational diabetes mellitus during the SARS-CoV-2 pandemic.
Aust N Z J Obstet Gynaecol
; 60(5): 660-666, 2020 10.
Article
in English
| MEDLINE | ID: covidwho-703592
ABSTRACT
The balance between avoiding severe acute respiratory syndrome coronavirus-2 contagion and reducing wider clinical risk is unclear for gestational diabetes mellitus (GDM) testing. Recent recommendations promote diagnostic approaches that limit collection but increase undiagnosed GDM, which potentially increases adverse pregnancy outcome risks. The most sensitive approach to detecting GDM at 24-28 weeks beyond the two-hour oral glucose tolerance test (OGTT) is a one-hour OGTT (88% sensitivity). Less sensitive approaches use fasting glucose alone (≥5.1 mmol/L misses 44-54% GDM) or asking ~20% of women for a second visit (fasting glucose 4.7-5.0 mmol/L (62-72% sensitive)). Choices should emphasise local and patient decision-making.
Keywords
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Main subject:
Patient Isolation
/
Pneumonia, Viral
/
Pregnancy Complications, Infectious
/
Prenatal Diagnosis
/
Diabetes, Gestational
/
Coronavirus Infections
/
Pandemics
Type of study:
Diagnostic study
/
Observational study
/
Prognostic study
Limits:
Adult
/
Female
/
Humans
/
Pregnancy
Language:
English
Journal:
Aust N Z J Obstet Gynaecol
Year:
2020
Document Type:
Article
Affiliation country:
Ajo.13224
Similar
MEDLINE
...
LILACS
LIS